Beyond Air (XAIR) Convertible Debt (2015 - 2016)
Beyond Air (XAIR) posted Convertible Debt of $2.9 million for Q4 2016, up 86.53% sequentially from $1.6 million in Q4 2015, and up 86.53% YoY from $1.6 million in Q1 2016.
Beyond Air (XAIR) Convertible Debt (2015 - 2016) Analysis & Trends
Beyond Air has reported Convertible Debt for 2 years, with the latest figure at $2.9 million in Q4 2016.
- Quarterly Convertible Debt rose 86.53% year-over-year to $2.9 million in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $2.9 million (up 86.53% YoY) and the FY2016 annual result came in at $2.9 million, up 86.53% from the prior year.
- Convertible Debt grew to $2.9 million in Q4 2016 per XAIR's latest filing, from $1.6 million in the prior quarter.
- Over five years, Convertible Debt peaked at $2.9 million in Q4 2016 and troughed at $1.6 million in Q4 2015.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Beyond Air | 3.72 Mn | -7.19 Mn | 225,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2016 | 2.90 Mn |
| Dec 31, 2015 | 1.55 Mn |